Exact Sciences clears big hurdle on the path to FDA review
270
post-template-default,single,single-post,postid-270,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Exact Sciences clears big hurdle on the path to FDA review

Exact Sciences clears big hurdle on the path to FDA review

Exact Sciences, located at URP, successfully cleared another hurdle in the rollout of its Cologuard product, a non-invasive screening test for colorectal cancer. Next week, an FDA panel will review Exact Sciences’ pre-market approval application. Read more [more-link]